These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 23150696)
21. Hodgkin lymphoma in a bone marrow aspirate. Parsons K; Leach M; Bain BJ Am J Hematol; 2020 Mar; 95(3):328-329. PubMed ID: 31849091 [No Abstract] [Full Text] [Related]
22. Malignant lymphoma: bone marrow imaging versus biopsy. Linden A; Zankovich R; Theissen P; Diehl V; Schicha H Radiology; 1989 Nov; 173(2):335-9. PubMed ID: 2678249 [TBL] [Abstract][Full Text] [Related]
23. Bone marrow signal during PET imaging in Hodgkin lymphoma. Fyfe A; McKay P; Leach M Br J Haematol; 2010 Apr; 149(2):165. PubMed ID: 20015301 [No Abstract] [Full Text] [Related]
24. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma. Cheson BD Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377 [TBL] [Abstract][Full Text] [Related]
25. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging. Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658 [TBL] [Abstract][Full Text] [Related]
26. FDG PET for imaging pericardial manifestations of Hodgkin lymphoma. Buchmann I; Wandt H; Wahl A; Reske SN Clin Nucl Med; 2003 Sep; 28(9):760-1. PubMed ID: 12973000 [TBL] [Abstract][Full Text] [Related]
27. [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. Purz S; Mauz-Körholz C; Körholz D; Hasenclever D; Krausse A; Sorge I; Ruschke K; Stiefel M; Amthauer H; Schober O; Kranert WT; Weber WA; Haberkorn U; Hundsdörfer P; Ehlert K; Becker M; Rössler J; Kulozik AE; Sabri O; Kluge R J Clin Oncol; 2011 Sep; 29(26):3523-8. PubMed ID: 21825262 [TBL] [Abstract][Full Text] [Related]
28. Intravenacaval invasion of classical Hodgkin lymphoma detected with Makita S; Kurihara H; Tobinai K Lancet Oncol; 2017 Apr; 18(4):e233. PubMed ID: 28368262 [No Abstract] [Full Text] [Related]
29. Hodgkin's lymphoma mimicking juvenile arthritis. Del Torto M; Breda L; Di Marzio D; De Sanctis S; La Barba G; Chiarelli F Clin Exp Rheumatol; 2010; 28(1):143. PubMed ID: 20346256 [No Abstract] [Full Text] [Related]
30. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Even-Sapir E; Lievshitz G; Perry C; Herishanu Y; Lerman H; Metser U Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534 [TBL] [Abstract][Full Text] [Related]
31. (18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma. Ujjani CS; Hill EM; Wang H; Nassif S; Esposito G; Ozdemirli M; Cordova C; Cheson BD Br J Haematol; 2016 Aug; 174(3):410-6. PubMed ID: 27098364 [TBL] [Abstract][Full Text] [Related]
32. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow]. Reske SN; Karstens JH; Glöckner WM; Ammon J; Büll U Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012 [TBL] [Abstract][Full Text] [Related]
33. Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma. Adams HJ; Kwee TC J Clin Oncol; 2015 Apr; 33(10):1217. PubMed ID: 25691675 [No Abstract] [Full Text] [Related]
34. Proceedings: The clinical evaluation and staging of patients with malignant lymphoma. Rosenberg SA Proc Natl Cancer Conf; 1972; 7():369-74. PubMed ID: 4764912 [No Abstract] [Full Text] [Related]
35. Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma. Altehoefer C; Blum U; Bathmann J; Wüstenberg C; Uhrmeister P; Laubenberger J; Lange W; Schwarzkopf J; Moser E; Langer M J Clin Oncol; 1997 May; 15(5):1754-60. PubMed ID: 9164182 [TBL] [Abstract][Full Text] [Related]
36. Unusual discrepancy between CT and PET/CT in the initial staging of Hodgkin's lymphoma. Michelis FV; Exarhos DN; Tzannou IA; Karmiris T; Nikiforakis E Acta Oncol; 2011 Apr; 50(3):474-6. PubMed ID: 20715895 [No Abstract] [Full Text] [Related]
37. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions. Cerci JJ; Trindade E; Buccheri V; Fanti S; Coutinho AM; Zanoni L; Linardi CC; Celli M; Delbeke D; Pracchia LF; Pitela FA; Soares J; Zinzani PL; Meneghetti JC Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):314-20. PubMed ID: 21816369 [TBL] [Abstract][Full Text] [Related]
38. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420 [TBL] [Abstract][Full Text] [Related]
39. A rare case of primary thymic Hodgkin lymphoma in an elderly patient detected by 18F-FDG PET/CT. Treglia G; Lococo F; Petrone G; Stefanelli A; Carnassale G; Calcagni ML; Granone P; Giordano A Clin Nucl Med; 2013 May; 38(5):e236-8. PubMed ID: 23377412 [TBL] [Abstract][Full Text] [Related]